TP53 and neoplasm: During the course of our studies, it has been reported that inhibition of p53 regulation by MDM2 using CGM097 further constrained in vivo tumor growth in UM PDX models when combined with PKC inhibition, although this combination did not result in synergistic growth inhibition in vitro11.